W. Schmid‐Burgk

1.3k total citations · 1 hit paper
18 papers, 976 citations indexed

About

W. Schmid‐Burgk is a scholar working on Pharmacology, Psychiatry and Mental health and Cellular and Molecular Neuroscience. According to data from OpenAlex, W. Schmid‐Burgk has authored 18 papers receiving a total of 976 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pharmacology, 8 papers in Psychiatry and Mental health and 6 papers in Cellular and Molecular Neuroscience. Recurrent topics in W. Schmid‐Burgk's work include Treatment of Major Depression (7 papers), Neuroscience and Neuropharmacology Research (4 papers) and Electroconvulsive Therapy Studies (4 papers). W. Schmid‐Burgk is often cited by papers focused on Treatment of Major Depression (7 papers), Neuroscience and Neuropharmacology Research (4 papers) and Electroconvulsive Therapy Studies (4 papers). W. Schmid‐Burgk collaborates with scholars based in Switzerland, Germany and Brazil. W. Schmid‐Burgk's co-authors include H. H. Kornhuber, Daniel Claus, R. Amrein, M. Stabl, Wolfgang Becker, R. Jürgens, V. Diekmann, Kathleen Bizière, W. Hetzel and Márcio Versiani and has published in prestigious journals such as The British Journal of Psychiatry, Psychopharmacology and Acta Psychiatrica Scandinavica.

In The Last Decade

W. Schmid‐Burgk

18 papers receiving 923 citations

Hit Papers

Low cerebrospinal fluid glutamate in schizophrenic patien... 1980 2026 1995 2010 1980 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia
    1980 513 citations H. H. Kornhuber, W. Schmid‐Burgk et al. Neuroscience Letters profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
W. Schmid‐Burgk Switzerland 12 538 316 272 269 241 18 976
L. Bjerkenstedt Sweden 23 461 0.9× 713 2.3× 355 1.3× 282 1.0× 199 0.8× 50 1.4k
Monica M. Marcus Sweden 21 809 1.5× 380 1.2× 482 1.8× 167 0.6× 187 0.8× 44 1.2k
Don Goff United States 10 471 0.9× 596 1.9× 300 1.1× 161 0.6× 195 0.8× 13 1.3k
R Kawahara Japan 11 534 1.0× 167 0.5× 324 1.2× 254 0.9× 126 0.5× 26 1.0k
Jorge Pérez Italy 19 666 1.2× 433 1.4× 430 1.6× 226 0.8× 450 1.9× 30 1.4k
Shaun Jordan United States 14 589 1.1× 463 1.5× 298 1.1× 93 0.3× 196 0.8× 18 1.2k
G. J. Riley United Kingdom 8 513 1.0× 357 1.1× 244 0.9× 128 0.5× 87 0.4× 12 944
Akeo Kurumaji Japan 20 783 1.5× 220 0.7× 551 2.0× 162 0.6× 80 0.3× 58 1.4k
DavidS. Janowsky United States 5 351 0.7× 241 0.8× 312 1.1× 122 0.5× 260 1.1× 6 974
M.D.C. Simpson United Kingdom 15 755 1.4× 309 1.0× 432 1.6× 164 0.6× 80 0.3× 34 1.1k

Countries citing papers authored by W. Schmid‐Burgk

Since Specialization
Citations

This map shows the geographic impact of W. Schmid‐Burgk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Schmid‐Burgk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Schmid‐Burgk more than expected).

Fields of papers citing papers by W. Schmid‐Burgk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. Schmid‐Burgk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Schmid‐Burgk. The network helps show where W. Schmid‐Burgk may publish in the future.

Co-authorship network of co-authors of W. Schmid‐Burgk

This figure shows the co-authorship network connecting the top 25 collaborators of W. Schmid‐Burgk. A scholar is included among the top collaborators of W. Schmid‐Burgk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. Schmid‐Burgk. W. Schmid‐Burgk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Hartmann, D, Andrea M. Cesura, W. Schmid‐Burgk, & R. Amrein. (1995). Relevance of reversible inhibitors of monoamine oxidase type A and of reuptake inhibition for noradrenaline turnover. Acta Psychiatrica Scandinavica. 91(s386). 14–21. 1 indexed citations
2.
Lecrubier, Y., et al.. (1995). Moclobemide versus clomipramine in nonmelancholic, nonpsychotic major depression. Acta Psychiatrica Scandinavica. 92(4). 260–265. 11 indexed citations
3.
Moll, Etelka, et al.. (1994). Safety and Efficacy During Long-Term Treatment with Moclobemide. Clinical Neuropharmacology. 17. S74–S87. 19 indexed citations
4.
Amrein, R., W. Hetzel, M. Stabl, & W. Schmid‐Burgk. (1993). RIMA — A new concept in the treatment of depression with moclobemide. International Clinical Psychopharmacology. 7(3). 123–132. 27 indexed citations
5.
Amrein, R., et al.. (1992). Interactions of moclobemide with concomitantly administered medication: evidence from pharmacological and clinical studies. Psychopharmacology. 106(S1). S24–S31. 37 indexed citations
6.
Versiani, Márcio, Antônio Egídio Nardi, F D Mundim, Alberto J. Alves, & W. Schmid‐Burgk. (1990). Moclobemide, imipramine and placebo in the treatment of major depression. Acta Psychiatrica Scandinavica. 82(S360). 57–58. 8 indexed citations
7.
Versiani, Márcio, et al.. (1989). A Double-blind Comparative Trial of Moclobemide v. Imipramine and Placebo in Major Depressive Episodes. The British Journal of Psychiatry. 155(S6). 72–77. 60 indexed citations
8.
Stabl, M., Kathleen Bizière, W. Schmid‐Burgk, & R. Amrein. (1989). Review of comparative clinical trials. Moclobemide vs tricyclic antidepressants and vs placebo in depressive states.. PubMed. 28. 77–89. 32 indexed citations
9.
Gieschke, Ronald, W. Schmid‐Burgk, & R. Amrein. (1988). Interaction of moclobemide, a new reversible monoamine oxidase inhibitor with oral tyramine.. PubMed. 26. 97–104. 16 indexed citations
10.
Schmid‐Burgk, W., et al.. (1985). Diclofensine and Imipramine. Neuropsychobiology. 14(4). 173–180. 2 indexed citations
11.
Schmid‐Burgk, W.. (1984). Sakkadische Augenbewegungen und endogene Psychosen. Fortschritte der Neurologie · Psychiatrie. 52(2). 67–71. 2 indexed citations
12.
Schmid‐Burgk, W., Wolfgang Becker, R. Jürgens, & H. H. Kornhuber. (1983). Saccadic Eye Movements in Psychiatric Patients. Neuropsychobiology. 10(4). 193–198. 22 indexed citations
13.
Schmid‐Burgk, W., Wolfgang Becker, V. Diekmann, R. Jürgens, & H. H. Kornhuber. (1982). Disturbed smooth pursuit and saccadic eye movements in schizophrenia. European Archives of Psychiatry and Clinical Neuroscience. 232(5). 381–389. 48 indexed citations
14.
Schmid‐Burgk, W., et al.. (1982). Effects of amitriptyline on serum glutamate and free tryptophan in rats. European Archives of Psychiatry and Clinical Neuroscience. 232(5). 391–394. 13 indexed citations
15.
Schmid‐Burgk, W., et al.. (1982). Increased serum glutamate in depressed patients. European Archives of Psychiatry and Clinical Neuroscience. 232(4). 299–304. 133 indexed citations
16.
Schmid‐Burgk, W., et al.. (1981). Levels of total and free tryptophan in the plasma of endogenous and neurotic depressives. European Archives of Psychiatry and Clinical Neuroscience. 231(1). 35–39. 5 indexed citations
17.
Kornhuber, H. H., et al.. (1980). Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia. Neuroscience Letters. 20(3). 379–382. 513 indexed citations breakdown →
18.
Kornhuber, H. H., et al.. (1980). Reduction of cerebrospinal fluid glutamic acid in huntington's chorea and in schizophrenic patients. European Archives of Psychiatry and Clinical Neuroscience. 228(1). 7–10. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by L. Bjerkenstedt Breakdown of academic impact, for papers by Monica M. Marcus Breakdown of academic impact, for papers by Don Goff Breakdown of academic impact, for papers by R Kawahara Breakdown of academic impact, for papers by Jorge Pérez Breakdown of academic impact, for papers by Shaun Jordan Breakdown of academic impact, for papers by G. J. Riley Breakdown of academic impact, for papers by Akeo Kurumaji Breakdown of academic impact, for papers by DavidS. Janowsky Breakdown of academic impact, for papers by M.D.C. Simpson
Rankless by CCL
2026